{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:48:03Z","timestamp":1764402483823},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2010.06.037","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T04:36:35Z","timestamp":1278477395000},"page":"2212-2221","source":"Crossref","is-referenced-by-count":8,"title":["Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when administered concurrently with a pneumococcal conjugate vaccine: A randomized, open-label, phase 3 study"],"prefix":"10.1016","volume":"29","author":[{"given":"Henry H.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"51 & 52","key":"10.1016\/j.vaccine.2010.06.037_bib1","first-page":"1","article-title":"Recommended immunization schedules for persons aged 0 through 18 years\u2014United States, 2010","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2010.06.037_bib2","unstructured":"Centers for Disease Control and Prevention (CDC), Combination vaccines for childhood immunization, Recommendations of the Advisory Committee on Immunization Practices (ACIP), The American Academy of Pediatrics (AAP), The American Academy of Family Physicians (AAFP). MMWR Recomm Rep 48[RR-5]: 1\u201314; 1999."},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.037_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.037_bib4","first-page":"506","article-title":"Combination vaccine use and vaccination quality in a managed care population","volume":"13","author":"Happe","year":"2007","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.vaccine.2010.06.037_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/INF.0b013e318187d047","article-title":"Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population","volume":"28","author":"Happe","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.037_bib6","unstructured":"Centers for Disease Control and Prevention (CDC). ACIP provisional recommendations for the use of combination vaccines. Available: http:\/\/www.cdc.gov\/vaccines\/recs\/provisional\/downloads\/combo-vax-Aug2009-508.pdf [accessed 12.10.09]."},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.037_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0264-410X(97)00241-7","article-title":"Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis\u2013Haemophilus b conjugate vaccine administered to infants at two, four and six months of age","volume":"16","author":"Mills","year":"1998","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.037_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/hv.1.5.2079","article-title":"Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b conjugate) when administered as a fourth dose at 15 to 18 months of age","volume":"1","author":"Scheifele","year":"2005","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.037_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1542\/peds.2007-3317","article-title":"Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial","volume":"123","author":"Guerra","year":"2009","journal-title":"Pediatrics"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2010.06.037_bib10","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV\u2013Hib vaccine","volume":"21","author":"Schmitt","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2010.06.037_bib11","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.vaccine.2006.11.008","article-title":"Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine","volume":"25","author":"Partridge","year":"2007","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2010.06.037_bib12","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.vaccine.2006.03.032","article-title":"Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTaP-HBV-IPV\/Hib combination vaccine in healthy infants","volume":"24","author":"Knuf","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.037_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.037_bib14","unstructured":"ClincalTrials.gov Web site. Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel\u2122. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00772928?term=M5A07&rank=1 [accessed 29.04.10]."},{"key":"10.1016\/j.vaccine.2010.06.037_bib15","doi-asserted-by":"crossref","unstructured":"Pentacel [prescribing information]. Swiftwater, PA, USA: Sanofi Pasteur Inc.; 2008. Available: https:\/\/www.vaccineshoppe.com\/image.cfm?doc_id=11169&image_type=product_pdf [accessed 27.04.10].","DOI":"10.1016\/S1773-035X(08)73313-6"},{"key":"10.1016\/j.vaccine.2010.06.037_bib16","unstructured":"Prevnar [prescribing information]. Philadelphia, PA, USA: Wyeth Pharmaceuticals Inc.; 2008. Available: http:\/\/www.wyeth.com\/content\/showlabeling.asp?id=134 [accessed 27.04.10]."},{"key":"10.1016\/j.vaccine.2010.06.037_bib17","unstructured":"21 Code of Federal Regulations 312.32(a); 2008."},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.037_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/161.3.487","article-title":"Natural history of pertussis antibody in the infant and the effect on vaccine response","volume":"161","author":"Van Savage","year":"1990","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.06.037_bib19","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.vaccine.2005.11.021","article-title":"Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP. IPV\/PRP-T Hib and hepatitis B vaccines in infants 2\u20137 months of age","volume":"24","author":"Scheifele","year":"2006","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2010.06.037_bib20","first-page":"65","article-title":"Immunization coverage against invasive pneumococcal disease among children in the capital health region of Alberta","volume":"15","author":"Public Health Agency of Canada","year":"2005","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2010.06.037_bib21","series-title":"Presented at 44th annual interscience conference on antimicrobial agents and chemotherapy","article-title":"Impact of differing provincial Pneumococcal vaccination programs on invasive Pneumococcal disease in children","author":"Powis","year":"2004"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.037_bib22","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","article-title":"Decrease in hospital admissions for febrile seizures and reports of hypotonic\u2013hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT","volume":"112","author":"Le Saux","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.06.037_bib23","unstructured":"Center for Biologics Evaluation and Research (CBER). Vaccines licensed for immunization and distribution in the United States. FDA. Updated October 15, 2007. Available at http:\/\/www.fda.gov\/Cber\/vaccine\/licvacc.htm [accessed 14.10.09]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:05:14Z","timestamp":1559235914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10008480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X10008480"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}